Security key
04683R106
Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR)
CUSIP: 04683R106
Q2 2022 13F Holders as of 30 Jun 2022
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 57,566,762
- Total 13F value
- $408,727,109
- Share change
- +2,755,217
- Put/Call ratio
- 9%
- SEC-reported price per share
- $7.10
- Number of holders
- 122
- Value change
- +$19,469,875
- Number of buys
- 58
- Number of sells
- 56
- Shares outstanding
- 79,671,812
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2022
Institutions
122
Top holders
10
AVIR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2022
Previous quarter: Q1 2022
Atea Pharmaceuticals, Inc. SEC filings
Atea Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 04683R106
Recent filing periods:
Ownership snapshot
Top reported holders of AVIR - Atea Pharmaceuticals, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Mar 2022
13F
Lead comparable stake: 16%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 16%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
16%
VANGUARD GROUP INC
8.4%
BlackRock Finance, Inc.
8.3%
EcoR1 Capital, LLC
8%
Bain Capital Life Sciences Invest...
3.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
16%
|
$90,826,000
12,579,791 shares
|
— | 31 Mar 2022 |
| VANGUARD GROUP INC |
13F
Company
|
8.4%
|
$48,584,000
6,729,203 shares
|
— | 31 Mar 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
8.3%
|
$47,830,000
6,624,693 shares
|
— | 31 Mar 2022 |
| EcoR1 Capital, LLC |
13F
Company
|
8%
|
$45,779,000
6,340,639 shares
|
— | 31 Mar 2022 |
| Bain Capital Life Sciences Investors, LLC |
13F
Company
|
3.1%
|
$17,946,000
2,485,638 shares
|
— | 31 Mar 2022 |
| FEDERATED HERMES, INC. |
13F
Company
|
2.6%
|
$14,812,000
2,051,332 shares
|
— | 31 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
122
Shares
57,566,762
Rows available
122
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
121
Q2 2022 holders
122
Holder diff
1
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q2 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend